Your browser doesn't support javascript.
loading
Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab.
Sherlock, Sarah P; Palmer, Jeffrey; Wagner, Kathryn R; Abdel-Hamid, Hoda Z; Bertini, Enrico; Tian, Cuixia; Mah, Jean K; Kostera-Pruszczyk, Anna; Muntoni, Francesco; Guglieri, Michela; Brandsema, John F; Mercuri, Eugenio; Butterfield, Russell J; McDonald, Craig M; Charnas, Lawrence; Marraffino, Shannon.
Afiliación
  • Sherlock SP; Pfizer Inc, Cambridge, MA, USA. Sarah.Sherlock@pfizer.com.
  • Palmer J; Pfizer Inc, Cambridge, MA, USA.
  • Wagner KR; Kennedy Krieger Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Abdel-Hamid HZ; Division of Child Neurology, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA.
  • Bertini E; Unit of Neuromuscular Disease, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Tian C; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Mah JK; University of Cincinnati School of Medicine, Cincinnati, OH, USA.
  • Kostera-Pruszczyk A; Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Muntoni F; Department of Neurology, Medical University of Warsaw, ERN EURO-NMD, Warsaw, Poland.
  • Guglieri M; Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Brandsema JF; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle, UK.
  • Mercuri E; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Butterfield RJ; Pediatric Neurology, Catholic University, Rome, Italy.
  • McDonald CM; Centro Nemo, Fondazione Policlinico Gemelli IRCCS, Rome, Italy.
  • Charnas L; University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Marraffino S; University of California Davis Health, Sacramento, CA, USA.
J Neurol ; 269(8): 4421-4435, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35396602
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Distrofia Muscular de Duchenne Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: J Neurol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Distrofia Muscular de Duchenne Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: J Neurol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos